Publications by authors named "Karin Rallmann"

Claim this Profile
C
Comprehensive identification of pathogenic tandem repeat expansions in sporadic amyotrophic lateral sclerosis: advantages of long-read vs. short-read sequencing.
Eleonora Sabetta, Karin Rallmann, Jonas Bergquist, Pille Taba, Abigail L Pfaff

Exp Biol Med (Maywood)· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Whole blood transcriptome profile identifies motor neurone disease RNA biomarker signatures.
Sulev Kõks, Karin Rallmann, Mari Muldmaa, Jack Price, Abigail L Pfaff

Exp Biol Med (Maywood)· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized, double-blind, placebo-controlled phase 2 study to assess safety, tolerability, and efficacy of RT001 in patients with amyotrophic lateral sclerosis.
Daphne N Weemering, Mark Midei, Peter Milner, Vidhya Gopalakrishnan, Anil Kumar, Karin Rallmann

Eur J Neurol· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relationship between the MDS-UPDRS and Quality of Life: A large multicenter study of 3206 patients.
Matej Skorvanek, Pablo Martinez-Martin, Norbert Kovacs, Ivan Zezula, Mayela Rodriguez-Violante, Karin Rallmann

Parkinsonism Relat Disord· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differences in MDS-UPDRS Scores Based on Hoehn and Yahr Stage and Disease Duration.
Matej Skorvanek, Pablo Martinez-Martin, Norbert Kovacs, Mayela Rodriguez-Violante, Jean-Christophe Corvol, Karin Rallmann

Mov Disord Clin Pract· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis